4D Molecular Therapeutics Funding & Investors
4d Molecular Therapeutics, LLC operates as a biotechnology company. The Company designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions. 4d Molecular Therapeutics serves customers in the State of California.
4dmoleculartherapeutics.comTotal Amount Raised: $595,000,000
4D Molecular Therapeutics Funding Rounds
Post Ipo Equity
$120,000,000
Series C
$75,000,000
Series C Investors
Viking Global InvestorsCystic Fibrosis FoundationRidgeback CapitalAmzak Health InvestorsArrowMark PartnersCasdin CapitalPerceptive AdvisorsBerkeley Catalyst FundPfizer Venture InvestmentsQUAD Investment ManagementChiesi VenturesPappas CapitalBiotechnology Value FundMirae Asset GroupLongevity Vision FundOctagon Capital AdvisorsSeries B
$90,000,000
Series B Investors
Viking Global InvestorsCureDuchenne VenturesRidgeback CapitalMirae AssetPerceptive AdvisorsArrowMark PartnersJanus HendersonPappas CapitalPfizer Venture InvestmentsBerkeley Catalyst FundChiesi VenturesBiotechnology Value FundSeries Unknown
$3,000,000
Series Unknown Investors
Cystic Fibrosis FoundationSeries Unknown
$6,999,995
Post Ipo Equity
$300,000,000
Funding info provided by Diffbot.